FEMASYS INC 8-K

What Happened

• On December 23, 2025, Femasys Inc. (FEMY) filed a prospectus supplement to offer and sell shares of its common stock (par value $0.001) having an aggregate offering price of up to $9,800,000.
• The sales will be made under an existing Equity Distribution Agreement dated July 1, 2022, with Piper Sandler & Co., and pursuant to the company’s previously filed Form S‑3 registration statement (File No. 333‑288527). The offering will use an "at‑the‑market" method as defined in Rule 415(a)(4) of the Securities Act.

Key Details

• Aggregate authorization: up to $9,800,000 of common stock.
• Sales agent: Piper Sandler & Co., under the Equity Distribution Agreement dated July 1, 2022.
• Filing date: prospectus supplement filed December 23, 2025; offering conducted under Form S‑3 (Reg. S‑3 File No. 333‑288527).
• Sales method: "at‑the‑market" (ATM) offering — shares may be sold from time to time at the company’s discretion; Piper Sandler will use commercially reasonable efforts to sell based on company instructions.

Why It Matters

• This filing gives Femasys a ready way to raise up to $9.8M of capital over time without a fixed secondary offering date. That can help fund operations or other corporate needs as market conditions allow.
• ATM offerings can dilute existing shareholders because new shares may be issued when sales occur; the filing itself does not mean any shares have been sold yet. Investors should watch subsequent SEC filings (e.g., Form 8‑K or sales notices) for actual amounts sold, pricing, and how proceeds are used.